There is clear evidence of rapid, nongenomic responses to estrogen in a variety of neuronal model systems. To address the question of whether some of these rapid estrogen signals might be transduced by the classical estrogen receptor (ER) α or a closely related protein in nontransformed neurons, we undertook the present study using isolated fetal rat hippocampal neurons. Several antibodies developed to detect ERα were tested in this system and showed positive membrane staining in nonpermeabilized neurons. MC-20, an affinity purified anti-ERα, rabbit polyclonal IgG antibody which does not recognize ERβ was selected to carry out the majority of the experiments. When permeabilized, the hippocampal neurons exhibited low levels of nuclear staining for ERα, but abundant labeling for ERα throughout the entire cell including the neurites. In addition to traditional immunocytochemistry controls, incubation of neurons for 24 h in the presence of 10 µM antisense oligonucleotide directed against the translation start site of ERα reduced ERα immunoreactivity throughout the neurons providing further evidence that the immunostaining was specific for ERα. Confocal and conventional microscopy demonstrated that the antigen was predominately extranuclear and localization of ERα in the neurites suggests that the receptor is in close proximity to the plasma membrane. This localization is consistent with a role for ERα as a transducer of rapid, nongenomic estrogen responses in hippocampal neurons.

Keywords:
Membrane steroid receptors, Hippocampal neurons, Gonadal steroid receptors, Immunocytochemistry
1.
Micevych PE, Hammer RPJ (eds): Neurobiological effects of sex steroid hormones. New York, Cambridge University Press, 1995.
2.
Mermelstein PG, Becker JB, Surmeier DJ: Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 1996;16:595–604.
3.
Singh M, Setalo G, Guan X, Warren M, Toran-Allerand CD: Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 1999;19:1179–1188.
4.
Zhou Y, Watters JJ, Dorsa DM: Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 1996;137:2163–2166.
5.
Wickelgren I: Estrogen stakes claim to cognition. Science 1997;276:675–679.
6.
Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999;19:2455–2463.
7.
Behl C, Widmann M, Trapp T, Holsboer F: 17β-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995;216:473–482.
8.
Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988;240:889–895.
9.
Carson-Jurica MA, Schrader WT, O’Malley BW: Steroid receptor family: Structure and functions. Endocr Rev 1990;11:201–220.
10.
Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JÅ: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925–5930.
11.
Watson CS, Gametchu B, Norfleet AM, Cambell CH, Thomas ML: Rapid, nongenomic actions of estrogens. Women Cancer 1998;1:21–28.
12.
Gu Q, Moss RL: Novel mechanism for non-genomic action of 17β-oestradiol on kainate-induced currents in isolated rat CA1 hippocampal neurons. J Physiol 1998;506:745–754.
13.
Becker JB: Direct effect of 17-beta-estradiol on striatum: Sex differences in dopamine release. Synapse 1990;5:157–164.
14.
Becker JB, Beer ME, Robinson TE: Striatal dopamine release stimulated by amphetamine or potassium: Influence of ovarian hormones and the light-dark cycle. Brain Res 1984;311:157–160.
15.
Pappas TC, Gametchu B, Watson CS: Membrane estrogen receptor-enriched GH3/B6 cells have an enhanced non-genomic response to estrogen. Endocrine 1995;3:743–749.
16.
Pappas TC, Gametchu B, Yannariello-Brown J, Collins TJ, Watson CS: Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 1994;2:813–822.
17.
Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 1999;13:307–319.
18.
Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn RE, Shaul P: Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401–406.
19.
Blaustein JD: Cytoplasmic estrogen receptors in rat brain: Immunocytochemical evidence using three antibodies with distinct epitopes. Endocrinology 1992;131:1336–1342.
20.
Blaustein JD: Estrogen receptor immunoreactivity in rat brain: Rapid effects of estradiol injection. Endocrinology 1993;132:1218–1224.
21.
Blaustein JD, Lehman MN, Turcotte JC, Greene G: Estrogen receptors in dendrites and axon terminals in the guinea pig hypothalamus. Endocrinology 1992;131:281–290.
22.
Wagner CK, Silverman AJ, Morrell JI: Evidence for estrogen receptor in cell nuclei and axon terminals within the lateral habenula of the rat: Regulation during pregnancy. J Comp Neurol 1998;392:330–342.
23.
Maggi A, Susanna E, Bettini E, Mantero G, Zucchi I: Hippocampus: A target for estrogen action in mammalian brain. Mol Endocrinol 1989;3:1165–1170.
24.
Bettini E, Pollio G, Santagati S, Maggi A: Estrogen receptor in rat brain: Presence in the hippocampal formation. Neuroendocrinology 1992;56:502–508.
25.
Gould E, Woolley CS, Frankfurt M, McEwen BS: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286–1291.
26.
Murphy DD, Segal M: Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 1996;16:4059–4068.
27.
Banker GA, Cowan WM: Rat hippocampal neurons in dispersed cell culture. Brain Res 1977;126:397–425.
28.
Evans MS, Collings MA, Brewer GJ: Electrophysiology of embryonic, adult and aged rat hippocampal neurons in serum-free culture. J Neurosci Methods 1998;79:37–46.
29.
Norfleet AM, Thomas ML, Watson CS: Estrogen receptor alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F-10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 1999;140:3805–3813.
30.
Brewer GJ, Torricelli JR, Evege EK, Price PJ: Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J Neurosci Res 1993;35:567–576.
31.
Xu X, Thomas ML: Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol 1994;105:197–201.
32.
Greene GL, Sobel NB, King WJ, Jensen EV: Immunochemical studies of estrogen receptors. J Steroid Biochem 1984;20:51–56.
33.
Xiao L, Becker JB: Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release. Synapse 1998;29:379–391.
34.
Anderson RG: The caveolae membrane system. Annu Rev Biochem 1998;67:199–225.
35.
Kelly PA, Postel-Vinay MC, Finidori J, Edery M, Sotiropoulos A, Goujon L, Esposito N: Growth hormone receptor structure, dimerization and function. Acta Paediatr 1994;83(suppl 399):107–111.
36.
Szego CM: Parallels in the modes of action of peptide and steroid hormones: Membrane effects and cellular entry; in Kearns KW (ed): Structure and Function of the Gonadotropins. New York, Plenum, 1978, pp 431–472.
37.
Szego CM: Cytostructural correlates of hormone action: New common ground in receptor-mediated signal propagation for steroid and peptide agonists. Endocrine 1994;2:1079–1093.
38.
Berry M, Metzger D, Chambon P: Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 1990;9:2811–2818.
39.
Danielian PS, White R, Hoare SA, Fawell SE, Parker MG: Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol 1993;7:232–240.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.